AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,514.00p
   
  • Change Today:
    -78.00p
  • 52 Week High: 14,148.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.73m
  • Volume: 2,358,147
  • Market Cap: £209,565m
  • RiskGrade: 123
  • Beta: 1.23

Latest Deals

Traded Action Notifier PriceAmountValue
12-Nov-25 Sell Aradhana Sarin 6,748.89p 15,000 £1,012,333.20
07-Nov-25 Transfer To Pascal Soriot 0.000p 136,537 £0.00
09-Sep-25 Buy Karen Knudsen 11,983.78p 5 £599.19
14-Aug-25 Sell Aradhana Sarin 11,511.70p 9,563 £1,100,863.84
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07
06-Mar-25 Transfer From Pascal Soriot 0.000p 89,962 £0.00
05-Mar-25 Buy Dividends Aradhana Sarin 0.000p 28 £0.00
05-Mar-25 Buy Dividends Pascal Soriot 0.000p 248 £0.00
04-Mar-25 Transfer From Aradhana Sarin 0.000p 2,021 £0.00
04-Mar-25 Transfer From Pascal Soriot 0.000p 17,357 £0.00

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,514.00p
Change Today -78.00p
% Change -0.57 %
52 Week High 14,148.00p
52 Week Low 9,667.00p
Volume 2,358,147
Shares Issued 1,550.73m
Market Cap £209,565m
Beta 1.23
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 10-Dec-2025

Time Volume / Share Price
15:01 235,000 @ 13,482.00p
15:03 235,000 @ 13,482.00p
16:48 24 @ 13,514.00p
16:48 998 @ 13,514.00p
16:47 4,102 @ 13,630.06p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page